Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips After soaring 278% yesterday, Invitae (NYSE: NVTA ) is falling over 40% in early trading today. NVTA stock might be undergoing a short squeeze. The company develops genetic tests that evaluate people’s ri...
Gainers: T2 Biosystems ( TTOO ) +73% . Veru ( VERU ) +38% . Ginkgo Bioworks ( DNA ) +21% . Inotiv ( NOTV ) +20% . Accuray ( ARAY ) +17% . Losers: Athenex ( ATNX ) -46% . Invitae ( NVTA ) -43% . Cer...
Athenex ( ATNX ) -41% on pricing $30M in stock and warrants offering . Invitae ( NVTA ) -25% . Hyperfine ( HYPR ) -17% on Q2 earnings release . Sonos ( SONO ) -17% on Q3 earnings release . Six Flags Entertainment ( SIX ) ...
3 Popular Penny Stocks To Watch Right Now Finding popular penny stocks in 2022 is not easy. But, by utilizing news and paying attention to how stocks are trading, you can find some of the best penny stocks to buy in 2022. Recently, we’ve begun to see a new round of bullish in...
Gainers: Euro Tech Holdings ( CLWT ) +63% . Invitae ( NVTA ) +59% . Allego ( ALLG ) +54% . Grove Collaborative ( GROV ) +52% . BioAtla ( BCAB ) +40% . The Trade Desk ( TTD ) +37% . Chicken Soup for the Soul Entert...
Invitae ( NYSE: NVTA ) shares are up 57% in Wednesday afternoon trading boosted by Q2 2022 earnings that beat on the top and bottom lines and a reaffirmation of 2022 guidance . The medical genetics company expects a low double-digit growth rate for its full year 2022 r...
Shares of Invitae (NYSE: NVTA) were skyrocketing 53.5% as of 11:14 a.m. ET on Wednesday. The huge gain came after the medical genetics company announced its second-quarter results following the market close on Tuesday. Second-quarter revenue was $136.6 million, up 17.5% year ove...
Behind the scenes movements continue in multiple ETFs. Flagship fund ARKK is now essentially buying and selling in same day. Transparency is a key as ARKK ETF's performance continues to deteriorate. Back in late March, I detailed how there was some unusual activity goi...
Image source: The Motley Fool. Invitae (NYSE: NVTA) Q2 2022 Earnings Call Aug 09, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Invitae (NVTA) Q2 2022 Earnings Call Transcript
The following slide deck was published by Invitae Corporation in conjunction with their 2022 Q2 earnings call. For further details see: Invitae Corporation 2022 Q2 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...